Brian D Cholewa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In melanoma, mutant and thereby constantly active neuroblastoma rat sarcoma (NRAS) affects 15-20% of tumors, contributing to tumor initiation, growth, invasion, and metastasis. Recent therapeutic approaches aim to mimic RAS extinction by interfering with critical signaling pathways downstream of the mutant protein. This study investigates the(More)
  • 1